Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1987 2
2002 29
2003 37
2004 43
2005 33
2006 30
2007 33
2008 39
2009 36
2010 32
2011 33
2012 24
2013 31
2014 38
2015 51
2016 36
2017 34
2018 37
2019 39
2020 57
2021 90
2022 76
2023 51
2024 57

Text availability

Article attribute

Article type

Publication date

Search Results

877 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. Among authors: jackson dj. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
A conditional knockout resource for the genome-wide study of mouse gene function.
Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, Mujica AO, Thomas M, Harrow J, Cox T, Jackson D, Severin J, Biggs P, Fu J, Nefedov M, de Jong PJ, Stewart AF, Bradley A. Skarnes WC, et al. Among authors: jackson d. Nature. 2011 Jun 15;474(7351):337-42. doi: 10.1038/nature10163. Nature. 2011. PMID: 21677750 Free PMC article.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators. Jackson DJ, et al. Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7. Lancet. 2024. PMID: 38071986 Free article. Clinical Trial.
Hyaluronan Receptor LYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen.
Lim HY, Lim SY, Tan CK, Thiam CH, Goh CC, Carbajo D, Chew SHS, See P, Chakarov S, Wang XN, Lim LH, Johnson LA, Lum J, Fong CY, Bongso A, Biswas A, Goh C, Evrard M, Yeo KP, Basu R, Wang JK, Tan Y, Jain R, Tikoo S, Choong C, Weninger W, Poidinger M, Stanley RE, Collin M, Tan NS, Ng LG, Jackson DG, Ginhoux F, Angeli V. Lim HY, et al. Among authors: jackson dg. Immunity. 2018 Aug 21;49(2):326-341.e7. doi: 10.1016/j.immuni.2018.06.008. Epub 2018 Jul 24. Immunity. 2018. PMID: 30054204 Free article.
Sleep and asthma.
Kavanagh J, Jackson DJ, Kent BD. Kavanagh J, et al. Among authors: jackson dj. Curr Opin Pulm Med. 2018 Nov;24(6):569-573. doi: 10.1097/MCP.0000000000000526. Curr Opin Pulm Med. 2018. PMID: 30199406 Review.
Utility of boron in dermatology.
Jackson DG, Cardwell LA, Oussedik E, Feldman SR. Jackson DG, et al. J Dermatolog Treat. 2020 Feb;31(1):2-12. doi: 10.1080/09546634.2017.1363850. Epub 2019 Oct 17. J Dermatolog Treat. 2020. PMID: 28789577 Review.
Plasmodesmata spread their influence.
Jackson D. Jackson D. F1000Prime Rep. 2015 Mar 3;7:25. doi: 10.12703/P7-25. eCollection 2015. F1000Prime Rep. 2015. PMID: 25926976 Free PMC article. Review.
Bioinformatics.
Jackson DB, Minch E, Munro RE. Jackson DB, et al. EXS. 2003;(93):31-69. doi: 10.1007/978-3-0348-7997-2_3. EXS. 2003. PMID: 12613171 Review. No abstract available.
CLAVATA-WUSCHEL signaling in the shoot meristem.
Somssich M, Je BI, Simon R, Jackson D. Somssich M, et al. Among authors: jackson d. Development. 2016 Sep 15;143(18):3238-48. doi: 10.1242/dev.133645. Development. 2016. PMID: 27624829 Review.
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.
Djukanović R, Brinkman P, Kolmert J, Gomez C, Schofield J, Brandsma J, Shapanis A, Skipp PJS, Postle A, Wheelock C, Dahlen SE, Sterk PJ, Brown T, Jackson DJ, Mansur A, Pavord I, Patel M, Brightling C, Siddiqui S, Bradding P, Sabroe I, Saralaya D, Chishimba L, Porter J, Robinson D, Fowler S, Howarth PH, Little L, Oliver T, Hill K, Stanton L, Allen A, Ellis D, Griffiths G, Harrison T, Akenroye A, Lasky-Su J, Heaney L, Chaudhuri R, Kurukulaaratchy R; SoMOSA study team and the U-BIOPRED study team. Djukanović R, et al. Among authors: jackson dj. Am J Respir Crit Care Med. 2024 Aug 1;210(3):288-297. doi: 10.1164/rccm.202310-1730OC. Am J Respir Crit Care Med. 2024. PMID: 38635834 Free PMC article.
877 results